TerSera Therapeutics USA
http://www.jdptherapeutics.com/Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 14, 2013 | Biotech startup developing drug to treat acute allergic reactions raises fresh capital | In home settings, where people would be more likely to suffer from an allergic reaction from food or a bee sting, the standard of care is an injection of epinephrine, followed by a trip to the emergency room where patients would get diphenh... |
| Biotech startup developing drug to treat acute allergic reactions raises fresh capital | A biotechnology startup is developing a small molecule drug it hopes could offer an alternative to the current standard of care for patients who suffer from an acute allergic reaction in hospital and home settings for the first time in more... |
Reviews 0
FAQ about TerSera Therapeutics USA
When was TerSera Therapeutics USA founded?
TerSera Therapeutics USA was founded in 2009.
How much funding has TerSera Therapeutics USA raised?
TerSera Therapeutics USA has raised $17M in total across 1 funding round.
What has the press written about TerSera Therapeutics USA?
Parsers VC has collected 3 articles mentioning TerSera Therapeutics USA, among them “Biotech startup developing drug to treat acute allergic reactions raises fresh capital” (Mar 14, 2013) and “Biotech startup developing drug to treat acute allergic reactions raises fresh capital”.
Is TerSera Therapeutics USA still active?
Yes, TerSera Therapeutics USA is active; its latest activity on Parsers VC dates from Jun 28, 2016.